John Grumitt

John Grumitt is an accomplished healthcare executive with extensive experience in leadership roles across various organizations. Currently serving as the Chief Executive Officer of Future Care Capital, John advises on scaling innovations to enhance health and care delivery. Additional positions include Medical Liaison Advisor at Tetris Pharma Limited, where guidance is provided for product launch strategies in Europe, and International Business Development at Myndlift, focusing on digital neurofeedback treatments for ADHD and anxiety. John chairs the IDEAL Group and C3 Collaborating for Health, contributing to advancements in diabetes care and addressing non-communicable diseases. With a long-standing involvement as Vice President Ambassador at Diabetes UK and a history of consultancy, John combines strategic insight and robust financial acumen, backed by a Chartered Accountant designation from ICAEW and executive training from The Wharton School.